PatientsVille.com Logo

ASCITES and Clindamycin

PatientsVille

ASCITES Symptoms and Causes

Cirrhosis is scarring of the liver. Scar tissue forms because of injury or long-term disease. Scar tissue cannot do what healthy liver tissue does - make protein, help fight infections, clean the blood, help digest food and store energy. Cirrhosis can lead to

  • Easy bruising or bleeding, or nosebleeds
  • Swelling of the abdomen or legs
  • Extra sensitivity to medicines
  • High blood pressure in the vein entering the liver
  • Enlarged veins called varices in the esophagus and stomach. Varices can bleed suddenly.
  • Kidney failure
  • Jaundice
  • Severe itching
  • Gallstones

A small number of people with cirrhosis get liver cancer.

Your doctor will diagnose cirrhosis with blood tests, imaging tests, or a biopsy.

Cirrhosis has many causes. In the United States, the most common causes are chronic alcoholism and hepatitis. Nothing will make the scar tissue disappear, but treating the cause can keep it from getting worse. If too much scar tissue forms, you may need to consider a liver transplant.

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Check out the latest treatments for ASCITES

ASCITES treatment research studies

Clindamycin clinical trials, surveys and public health registries


Find Drug Side Effect reports



Clindamycin Side Effects

Diarrhoea (245)
Rash (142)
Nausea (108)
Pruritus (101)
Vomiting (79)
Pyrexia (77)
Clostridium Difficile Colitis (68)
Dyspnoea (67)
Urticaria (61)
Erythema (59)
Abdominal Pain Upper (58)
Clostridial Infection (55)
Renal Failure Acute (50)
Abdominal Pain (49)
Dizziness (49)
Pain (48)
Dysphagia (43)
Headache (41)
Dyspepsia (41)
Hypersensitivity (39)
Asthenia (38)
Chest Pain (38)
Weight Decreased (35)
Rash Pruritic (35)
Fatigue (34)
Malaise (33)
Rash Erythematous (33)
Swelling Face (32)
Pseudomembranous Colitis (30)
Angioedema (30)
International Normalised Ratio Increased (29)
Dysgeusia (29)
Dehydration (28)
Oedema Peripheral (28)
Hypotension (27)
Chills (27)
Pancytopenia (26)
Rash Maculo-papular (25)
Stevens-johnson Syndrome (25)
Skin Exfoliation (25)
Colitis (24)
Arthralgia (23)
Abdominal Discomfort (23)
Abdominal Distension (22)
Alanine Aminotransferase Increased (22)
Pharyngeal Oedema (20)
Haematochezia (20)
Blister (20)
Gastrointestinal Disorder (19)
Renal Failure (19)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

I was given Clindamycin (150 MG Capsule) to take for 10 days 4 times daily for tooth extractions aftercare. It gives me splitting headaches and acid reflux . Evdokia

After taking Clindamycin 4 days for my tooth infection, I started heart burn pain, cough, difficult swollen food. Now I have stoped the drug 4 days, but I only can drink fluid. Any solid food cause me severe chest pain.

After taking the Clindamycin Capsules, I have nausea then it feels as if my chest is about to burst open, like i am about to choke which lasts at least 3 hours. I never felt like this in my life. Help!

Clindamycin has caused me such horrible heartburn. It effects everything I drink or eat. I have burning in my throat and tightness in my chest tonight as well. My ears itch and burn deep inside them and they are red and hot to the touch. Horrible fee

Clindamycin is a safe medicine. If you have an abcess or tooth infection it can be VERY dangerous to NOT take the antibiotic. You can alleviate a lot of the stomach discomfort by taking high quality PRO-BIOTICS and consuming a LOT of unsweetened yo

Does clindamycin interact with Fentanyl or "industrial-strength" diuretics? Is it possible for clindamycin by itself, or with one of the other 2, or both, to cause a sleep that is almost like unconciousness? My Dad had this happen recently

Have been taking clindamycin for 10 days now, I am usually very sensitive to antibiotics, have been loading myself up with pro-biotics which has helped, I do have quite a sore throat from it though bu it is bearable

Headaches, red rash on legs, fatigue

Hello. I went to a Dentist for "Tooth Infection". I was prescribed Clindamycin. It has been 9 days since I stopped taking the medication. About every 3 days I get stomach pain, then diarhea. I have also had flatulance. My only

How many days should we take it? I have an ear infection and my doctor wanted me to take it for 3 days. Antibiotics should be taken 7 days right?

I am searching for how oxycodone affects ascites.

Dear sir I want to inform that in using gliclazid in a patient with mild degree of hepatosplenomegally diagnosed as mild liver cirrhosis the patient state is detorated and develop mild ascites and moderate to severe lower limbe oedema

I have long term liver disease and ascites due to alcohol excess when I was younger. My doc has prescribed Aldactone 25 (three a day because I also have high blood pressure) but my oedema seems to be getting worse instead of better. I have noticed

My father developed Ascites but physicians do not think it is related to Revlimid. I am not sure but the timing of it coincides with the initial dosing of the medication.

ASCITES Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis
Conditions: Liver Cirrhosis;   Ascites
Interventions: Drug: Diuretics plus human albumin;   Drug: Diuretics (standard medical treatment)
Outcome Measures: Mortality;   Incidence of cirrhosis-related clinical complications;   Number of total paracentesis;   Number of patients potentially needing TIPS (3 paracentesis/month);   Quality of life;   Analysis of the cost/effectiveness ratio;   Incidence of refractory Ascites according to the IAC criteria
2 Recruiting ALFApump System Versus Standard of Care in Ascites Treatment
Condition: Refractory or Recurrent Ascites
Interventions: Device: ALFApump removal of Ascites;   Procedure: Large volume paracentesis
Outcome Measures: Paracentesis free survival;   Non-inferiority of cirrhosis related complication in the patient group treated with the ALFApump system;   Quality of Life;   Body weight;   Nutritional profile;   Resource utilisation;   Survival;   Assess the need for repeat evacuation paracentesis
3 Unknown  Infrared Ray Heat Treatment in Liver Cirrhosis Patients With Refractory Ascites
Conditions: Liver Cirrhosis;   Refractory Ascites
Interventions: Radiation: Infrared ray heat treatment;   Other: conventional treatment
Outcome Measure: Ascites pressure
4 Unknown  Albumin 4 gr/L vs 8 gr/L in the Prevention of Post-Paracentesis Circulatory Dysfunction
Condition: Tense Ascites in Cirrhosis
Interventions: Drug: albumin 4 gr/L Ascites removed;   Drug: albumin 8 gr/L Ascites removed
Outcome Measures: renin-angiotensin-aldosterone activation;   renal function
5 Recruiting Tolvaptan for Ascites in Cirrhotic Patients
Conditions: Ascites;   Cirrhosis
Intervention: Drug: Tolvaptan
Outcome Measures: Number of patients with worsening Ascites;   Number of patients with reduction of Ascites;   Number of Patients with Potentially Clinically Significant Abnormal Labs
6 Not yet recruiting Tolvaptan for Hyponatremia in Cirrhotic Patients With Ascites
Conditions: Hyponatremia;   Ascites
Interventions: Drug: Tolvaptan;   Drug: placebo
Outcome Measures: the change in the average daily area under the curve (AUC) for the serum sodium concentration from baseline to day 28 after intervention;   the change in the average daily area under the curve (AUC) for the serum sodium concentration from baseline to day 4;   the time to normalization of the serum sodium concentration;   the time to first paracentesis, number of paracentesis, the volume of ascitic fluid obtained from paracentesis;   Abdominal discomfort based on a 100-mm visual analogue scales (VAS);   The change in the dose of concomitant diuretics from baseline at day 28;   the number of participants with serious adverse events;   the time to Ascites improvement;   the time of worsening of Ascites
7 Recruiting Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and Albumin
Condition: Cirrhosis
Interventions: Drug: Terlipressin;   Drug: Placebo
Outcome Measures: Mean number of paracentesis between the 2 groups over a 6 months period;   Total Ascites retrieval;   Number of cirrhosis complications groups;   Liver transplantation and deaths;   Terlipressin safety;   Mean number of days of hospitalization;   Delay between inclusion and the first rehospitalisation for Ascites retrieval
8 Recruiting Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant Ascites
Condition: Refractory Malignant Ascites
Intervention: Drug: bevacizumab
Outcome Measures: adverse events;   Maximum tolerated dose;   Objective response rate;   time to treatment failure(TTF);   time to death(TTD)
9 Recruiting Conservative Treatment Versus Elective Repair of Umbilical Hernia in Patients With Ascites and Liver Cirrhosis
Conditions: Umbilical Hernia;   Liver Cirrhosis;   Ascites
Interventions: Procedure: Conservative treatment;   Procedure: Surgical repair
Outcome Measures: complications;   Recurrence;   Mortality;   Length of hospital stay;   Quality of life;   Cost effectiveness
10 Recruiting Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side Effects
Conditions: Ascites;   Cirrhosis
Intervention: Drug: Eplerenone
Outcome Measure: Ascites
11 Recruiting Evaluation of the Strip PeriScreen for the Fast Diagnosis of the Spontaneous Infection of the Liquid of Ascites During the Cirrhosis
Conditions: Cirrhosis;   Liquid of Ascites;   Infection
Intervention: Other: strip Peri Screen
Outcome Measure: liquid of Ascites spontaneous infection
12 Unknown  Adrenal Insufficiency in Cirrhotics With Ascites. Effects of Hydrocortisone on Renal and Haemodynamic Function
Condition: Cirrhosis With Ascites
Interventions: Drug: hydrocortisone;   Drug: dextrose solution 5%
Outcome Measure: renal function
13 Recruiting Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites
Conditions: Malignant Pleural Effusion;   Malignant Ascites
Interventions: Drug: Endostar;   Drug: Cisplatin
Outcome Measures: Objective Response Rate;   Time to Progression;   Quality of Life;   Incidence of Adverse Events
14 Recruiting Clinical Trial on the Effects of Long Term Administration of 20% Albumin in the Cardiovascular and Renal Function, And Hepatic Hemodynamics in Advanced Patients With Cirrhosis and Ascites.
Conditions: Cirrhosis;   Ascites
Intervention: Drug: Albumin
Outcome Measures: To asses plasma renin activity and plasma concentration of noradrenaline;   Glomerular filtration;   Portal hypertension;   Cardiac Function
15 Recruiting VSL#3 and Spontaneous Bacterial Peritonitis
Condition: Decompensated Cirrhosis With Ascites.
Interventions: Drug: cotrimoxazole;   Drug: VSL#3 active;   Drug: VSL#3 placebo
Outcome Measures: Liver-related mortality and liver related morbidity;   Incidence of SBP, variceal bleeding, any non-SBP sepsis (e.g. pneumonia, urinary tract infection), clinical episodes of encephalopathy and the incidence of C. difficile infection.
16 Recruiting Body Composition Analysis in Cirrhotic Treated With Paracentesis
Conditions: Liver Cirrhosis;   Ascites
Intervention: Behavioral: Body composition in paracentesis
Outcome Measure: Body composition
17 Unknown  Prevention of Decompensation in Liver Cirrhosis
Conditions: Alcoholic Liver Cirrhosis;   Ascites
Intervention: Drug: losartan (drug)
Outcome Measures: Death;   varices;   need for therapeutic Ascites drainage;   gastrointestinal bleeding episodes
18 Recruiting Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis
Conditions: Liver Cirrhosis;   Ascites
Interventions: Drug: Rifaximin;   Drug: placebo
Outcome Measures: Change from baseline in Hepatic venous pressure gradient (HVPG);   Change from baseline in Glomerular filtration rate (GFR)
19 Recruiting Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites
Condition: Hyponatremia and Extracellular Fluid in Cirrhotic
Interventions: Drug: Tolvaptan;   Drug: Placebo
Outcome Measures: Serum Na;   BCM (body composition monitoring);   body weight;   A composite endpoint of Ascites worsening;   Serum Na normalization rate;   Biochemistry;   ECG;   Adverse event;   Physical examination;   Vital signs;   Blood coagulation;   Urinalysis
20 Recruiting Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion Chemotherapy
Condition: Ovarian Cancer With Malignant Ascites
Interventions: Drug: Bevacizumab;   Drug: TC:paclitaxel + carboplatin
Outcome Measure: objective response rate